The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Open accessAbstract
Polymer-based microparticles are in clinical use mainly for their ability to provide controlled release of peptides and compounds, but they are also being explored for their potential to deliver vaccines and drugs as suspensions directly into mucosal sites. It is generally assumed that uptake is mediated by epithelial M cells, but this is often not directly measured. To study the potential for optimizing M cell uptake of polymer microparticles in vivo, we produced sub-micron size PLGA particles incorporating a recombinant protein. This recombinant protein was produced with or without a c-terminal peptide previously shown to have high affinity binding to Claudin 4, a protein associated with M cell endocytosis. While the PLGA nanoparticles incorporate the protein throughout the matrix, much of the protein was also displayed on the surface, allowing us to take advantage of the binding activity of the targeting peptide. Accordingly, we found that instillation of these nanoparticles into the nasal passages or stomach of mice was found to significantly enhance their uptake by upper airway and intestinal M cells. Our results suggest that a reasonably simple nanoparticle manufacture method can provide insight into developing an effective needle-free delivery system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CPE30, the C-terminal 30 amino acid part of CPE, was coated to PLGA NPs, which increased the uptake by upper airways when administered intranasally or by intestinal M cells after ingestion [101].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [101]
In the citing paper
“The latter functions as a receptor for Clostridium perfringens enterotoxin (CPE) and has been recent focus for targeting approaches [101].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands
Sonoda, N., Furuse, M., Sasaki, H., Yonemura, S., Katahira, J., Horiguchi, Y., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.195 · Cited by 612
Rahner, C., Mitic, L. L., & Anderson, J. M. (2001) · Gastroenterology · doi:10.1053/gast.2001.21736 · Cited by 546
Jiang, W., Rk, G., DESHPANDE, M., & Schwendeman, S. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 480
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., & Gilley, R. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2978-2986.1991 · Cited by 365
Katahira, J., Inoue, N., Horiguchi, Y., Matsuda, M., & Sugimoto, N. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.6.1239 · Cited by 278
Katahira, J., Sugiyama, H., Inoue, N., Horiguchi, Y., Matsuda, M., & Sugimoto, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26652 · Cited by 273
Sansonetti, P. J., & Phalipon, A. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0175 · Cited by 269
How to achieve sustained and complete protein release from PLGA-based microparticles?
Giteau, A., Venier‐Julienne, M., Aubert‐Pouëssel, A., & Benoît, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.012 · Cited by 268
Crotts, G., & Park, T. G. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809008253 · Cited by 263
Blanco, D., & Alonso, M. J. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00011-3 · Cited by 252
Flagged first, then by citations
1 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Breton, A. L., & Véronique Préat, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 4,006
The intestinal epithelium: central coordinator of mucosal immunity
Allaire, J. M., Crowley, S. M., Law, H. T., Chang, S.-Y., Ko, H.-J., & Vallance, B. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.002 · Cited by 933
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 771
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium
Mabbott, N. A., Donaldson, D. S., Ohno, H., Williams, I. R., & Mahajan, A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.30 · Cited by 721
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Kou, L., Sun, J., Zhai, Y., & He, Z. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.001 · Cited by 588
Metadata
- Authors
- Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D.
- Affiliations
- University of California, Riverside (US)
- Corresponding author
- Lo, David D.
- ORCID
- Lo, David D.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 142
- Issue
- 2
- Pages
- 196-205
- ISSN
- 0168-3659 (ISSN-L)
- PMC
- PMC2823968
- OpenAlex
- W1973426656
- Cited by
- 137
- References
- 50
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 11 · 2022: 6 · 2021: 5 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 11 · 2012: 14
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Foundation for the National Institutes of Health
- Harvard University
- National Institute of Allergy and Infectious Diseases (AI73689, R01AI063426, R43AI058434, R21AI073689)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- claudin-4, M cells, PLGA nanoparticles, targeted drug delivery, mucosal drug delivery, nasal instillation, upper airway, vaccine delivery
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Biological Transport, Cell Line, Cricetulus, Drug Carriers, Cricetinae, Hemagglutinins, Membrane Proteins, Mucous Membrane, Influenza A virus, Peyer's Patches, Polyglycolic Acid, Recombinant Proteins, CHO Cells, Lactic Acid, Mice, Nanoparticles, Claudin-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
